155 related articles for article (PubMed ID: 10568423)
1. Elevation of serum hepatic aminotransferases during treatment of rheumatoid arthritis with low-dose methotrexate. Risk factors and response to folic acid.
Suzuki Y; Uehara R; Tajima C; Noguchi A; Ide M; Ichikawa Y; Mizushima Y
Scand J Rheumatol; 1999; 28(5):273-81. PubMed ID: 10568423
[TBL] [Abstract][Full Text] [Related]
2. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Tanjong Ghogomu E; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
Cochrane Database Syst Rev; 2013 May; 2013(5):CD000951. PubMed ID: 23728635
[TBL] [Abstract][Full Text] [Related]
3. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Shea B; Swinden MV; Ghogomu ET; Ortiz Z; Katchamart W; Rader T; Bombardier C; Wells GA; Tugwell P
J Rheumatol; 2014 Jun; 41(6):1049-60. PubMed ID: 24737913
[TBL] [Abstract][Full Text] [Related]
4. Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
Curtis JR; Beukelman T; Onofrei A; Cassell S; Greenberg JD; Kavanaugh A; Reed G; Strand V; Kremer JM
Ann Rheum Dis; 2010 Jan; 69(1):43-7. PubMed ID: 19147616
[TBL] [Abstract][Full Text] [Related]
5. Influence of High-Dose Folic Acid on Methotrexate Efficacies and Safety in Japanese Rheumatoid Arthritis Patients.
Kameyama S; Kase Y; Kurihara S; Yoshida F; Noda M; Iiduka T; Horiguchi M; Sugiyama K; Hirano T
Drug Res (Stuttg); 2017 Dec; 67(12):705-709. PubMed ID: 28898908
[No Abstract] [Full Text] [Related]
6. Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.
Kent PD; Luthra HS; Michet C
J Rheumatol; 2004 Sep; 31(9):1727-31. PubMed ID: 15338491
[TBL] [Abstract][Full Text] [Related]
7. Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategy.
Dirven L; Klarenbeek NB; van den Broek M; van Groenendael JH; de Sonnaville PB; Kerstens PJ; Huizinga TW; Dijkmans BA; Lems WF; Allaart CF
Clin Rheumatol; 2013 May; 32(5):585-90. PubMed ID: 23224330
[TBL] [Abstract][Full Text] [Related]
8. Aminotransferases are associated with insulin resistance and atherosclerosis in rheumatoid arthritis.
Dessein PH; Woodiwiss AJ; Joffe BI; Norton GR
BMC Cardiovasc Disord; 2007 Oct; 7():31. PubMed ID: 17967187
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.
Karlsson Sundbaum J; Eriksson N; Hallberg P; Lehto N; Wadelius M; Baecklund E
Int J Rheum Dis; 2019 Jul; 22(7):1226-1232. PubMed ID: 31012257
[TBL] [Abstract][Full Text] [Related]
10. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
García DS; Saturansky EI; Poncino D; Martínez-Artola Y; Rosenberg S; Abritta G; Ascimani-Peña C; Cravero A
Ann Hepatol; 2019; 18(5):765-769. PubMed ID: 31105018
[TBL] [Abstract][Full Text] [Related]
11. Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trial.
Iannone F; La Montagna G; Bagnato G; Gremese E; Giardina A; Lapadula G
J Rheumatol; 2014 Feb; 41(2):286-92. PubMed ID: 24429167
[TBL] [Abstract][Full Text] [Related]
12. Risk of hepatotoxicity with add-on leflunomide in rheumatoid arthritis patients.
Gupta R; Bhatia J; Gupta SK
Arzneimittelforschung; 2011; 61(5):312-6. PubMed ID: 21755815
[TBL] [Abstract][Full Text] [Related]
13. Quantitative liver function in patients with rheumatoid arthritis treated with low-dose methotrexate: a longitudinal study.
Beyeler C; Reichen J; Thomann SR; Lauterburg BH; Gerber NJ
Br J Rheumatol; 1997 Mar; 36(3):338-44. PubMed ID: 9133966
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of liver enzyme elevation in rheumatoid arthritis patients starting methotrexate.
Sundbaum JK; Baecklund E; Eriksson N; Kohnke H; Wallenberg M; Cavalli M; Wadelius C; Wadelius M; Hallberg P
Pharmacogenomics; 2021 Oct; 22(15):973-982. PubMed ID: 34521259
[No Abstract] [Full Text] [Related]
15. Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review.
Whittle SL; Hughes RA
Rheumatology (Oxford); 2004 Mar; 43(3):267-71. PubMed ID: 14963199
[TBL] [Abstract][Full Text] [Related]
16. Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.
Ortiz Z; Shea B; Suarez Almazor M; Moher D; Wells G; Tugwell P
Cochrane Database Syst Rev; 2000; (2):CD000951. PubMed ID: 10796393
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
van Ede AE; Laan RF; Blom HJ; Boers GH; Haagsma CJ; Thomas CM; De Boo TM; van de Putte LB
Rheumatology (Oxford); 2002 Jun; 41(6):658-65. PubMed ID: 12048292
[TBL] [Abstract][Full Text] [Related]
18. Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables.
Kremer JM; Kaye GI; Kaye NW; Ishak KG; Axiotis CA
Arthritis Rheum; 1995 Sep; 38(9):1194-203. PubMed ID: 7575712
[TBL] [Abstract][Full Text] [Related]
19. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
[TBL] [Abstract][Full Text] [Related]
20. Transient increase of aminotransferases in RA patients treated with methotrexate.
Lacki JK; Samborski W; Machiewicz SH
Z Rheumatol; 1993; 52(4):232-5. PubMed ID: 8212923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
